Literature DB >> 11035754

Hemolytic and hemoxidative activities in Mycoplasma penetrans.

T R Kannan1, J B Baseman.   

Abstract

Mycoplasma penetrans is a newly isolated Mollicute from the urine of patients infected with human immunodeficiency virus that demonstrates the capacity to adhere to and invade human cells. A previous report, based on assays with mouse red blood cells (RBCs), indicated that M. penetrans lacked hemolytic activity. In our studies, we incubated different isolates of M. penetrans with various RBC species and observed hemolytic zones surrounding individual mycoplasma colonies. All M. penetrans strains displayed hemolysis after 2 to 3 days of incubation. Hemolytic activity diffused from single colonies, eventually causing complete lysis. Hemolysis was most pronounced with sheep RBCs, followed by horse, chicken, and human cells. Furthermore, hemolytic activity was demonstrable in both intact mycoplasma cell preparations and spent culture supernatant. However, unlike intact mycoplasmas, the hemolytic activity in the supernatant was dependent on the reducing agent, cysteine. In addition to hemolysis, a brown precipitate was closely associated with mycoplasma colonies, suggesting oxidation of hemoglobin. Absorption spectra indicated that hemoglobin was oxidized to methemoglobin, and the addition of catalase demonstrated H(2)O(2)-mediated hemoxidation. Other experiments suggested that hemoxidation enhanced total hemolysis, providing the first evidence of both hemolytic and hemoxidative activities in M. penetrans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035754      PMCID: PMC97728          DOI: 10.1128/IAI.68.11.6419-6422.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Pore-forming bacterial protein hemolysins (cytolysins).

Authors:  V Braun; T Focareta
Journal:  Crit Rev Microbiol       Date:  1991       Impact factor: 7.624

2.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.

Authors:  R Himmelreich; H Hilbert; H Plagens; E Pirkl; B C Li; R Herrmann
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos.

Authors:  M M Hayes; B J Li; D J Wear; S C Lo
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios.

Authors:  T Honda; R A Finkelstein
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  The effect of thiol-active compounds and sterols on the membrane-associated hemolysin of Mycoplasma pulmonis.

Authors:  K J Jarvill-Taylor; F C Minion
Journal:  FEMS Microbiol Lett       Date:  1995-05-01       Impact factor: 2.742

6.  AIDS-associated mycoplasmas possess phospholipases C in the membrane.

Authors:  K Shibata; T Sasaki; T Watanabe
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide.

Authors:  E W Kellogg; I Fridovich
Journal:  J Biol Chem       Date:  1977-10-10       Impact factor: 5.157

8.  Characterization of hemolysis and hemoxidation activities by Treponema denticola.

Authors:  L Chu; W Kennell; S C Holt
Journal:  Microb Pathog       Date:  1994-03       Impact factor: 3.738

9.  Mycoplasma penetrans sp. nov., from the urogenital tract of patients with AIDS.

Authors:  S C Lo; M M Hayes; J G Tully; R Y Wang; H Kotani; P F Pierce; D L Rose; J W Shih
Journal:  Int J Syst Bacteriol       Date:  1992-07

10.  Membrane-associated hemolysin activities in mycoplasmas.

Authors:  F C Minion; K Jarvill-Taylor
Journal:  FEMS Microbiol Lett       Date:  1994-02-01       Impact factor: 2.742

View more
  8 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Mycoplasma pneumoniae Pneumonia Associated With Methemoglobinemia and Anemia: An Overlooked Association?

Authors:  Tawfik Khoury; Ayman Abu Rmeileh; Jonathan David Kornspan; Roy Abel; Meir Mizrahi; Ran Nir-Paz
Journal:  Open Forum Infect Dis       Date:  2015-03-12       Impact factor: 3.835

3.  Cardiolipin synthetase is involved in antagonistic interaction (reverse CAMP phenomenon) of Mycoplasma species with Staphylococcus aureus beta-hemolysis.

Authors:  Jonathan D Kornspan; Shlomo Rottem; Ran Nir-Paz
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948

4.  Characterization of a unique ADP-ribosyltransferase of Mycoplasma penetrans.

Authors:  Coreen Johnson; T R Kannan; Joel B Baseman
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

5.  Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy.

Authors:  Elvin Blanco; Erik A Bey; Chalermchai Khemtong; Su-Geun Yang; Jagadeesh Setti-Guthi; Huabing Chen; Chase W Kessinger; Kevin A Carnevale; William G Bornmann; David A Boothman; Jinming Gao
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 13.312

6.  Development of oriC-plasmids for use in Mycoplasma hyorhinis.

Authors:  Hassan Z A Ishag; Qiyan Xiong; Maojun Liu; Zhixin Feng; Guoqing Shao
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

Review 7.  Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Authors:  Chen Yiwen; Wu Yueyue; Qin Lianmei; Zhu Cuiming; You Xiaoxing
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

8.  Disruption of the S41 peptidase gene in mycoplasma mycoides capri impacts proteome profile, H(2)O(2) production, and sensitivity to heat shock.

Authors:  Ayman B Allam; Mary B Brown; Leticia Reyes
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.